B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP6V1B2

MOLECULAR TARGET

ATPase H+ transporting V1 subunit B2

UniProt: P21281NCBI Gene: 5261 compounds

ATP6V1B2 (ATPase H+ transporting V1 subunit B2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP6V1B2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Enoxacin1.102

About ATP6V1B2 as a Drug Target

ATP6V1B2 (ATPase H+ transporting V1 subunit B2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ATP6V1B2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP6V1B2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.